By way of example, in triple detrimental breast cancer (TNBC),25 As well as in hepatocellular carcinoma,26 DNA methylation profiles have aided on the identification of distinctive subgroups with clinical relevance. Epigenetic approaches have also helped to the development of prognostic tests to evaluate the sensitivity of cancer cells to https://directivepublications.org/world-journal-of-clinical-cancer-research/